State Of Wisconsin Investment Board Neoleukin Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

  • $37.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$9.23 - $13.12 $394,121 - $560,224
-42,700 Closed
0 $0
Q4 2020

Feb 03, 2021
SELL
$10.17 - $14.56 $53,901 - $77,168
-5,300 Reduced 11.04%
42,700 $602,000
Q3 2020

Nov 16, 2020
BUY
$9.68 - $17.01 $464,640 - $816,480
48,000 New
48,000 $576,000

Others Institutions Holding NLTX

# of Institutions
1
Shares Held
199K
Call Options Held
0
Put Options Held
0
View Full List

About Neoleukin Therapeutics, Inc.

NLTX Quotes by TradingView
  • Ticker NLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,579,900
  • Description
  • Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...
More about NLTX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email